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The two novel ion-pairs (PB-TPB and NB-TPB) of quaternary ammonium drugs; propantheline bro-
mide (PB), N,N-Diisopropyl-N-methyl-N-[2-(xanthen-9ylcarbonyloxy)ethyl] ammonium bromide and
neostigmine bromide (NB), 3-(dimethylcarbamoyloxy) phenyl]-trimethylazanium have been synthe-
sized, respectively and incorporated in poly (vinyl chloride)-based membrane electrodes for the
quantiﬁcation of propantheline bromide and neostigmine bromide in different pharmaceutical prepara-
tions. The inﬂuences of membrane compositions on the potentiometric responses of membrane electrodes
have been found to substantially improve the performance characteristics. The best performance was
reported with membranes having composition (w/w) of PB-TPB or NB-TPB (6%): PVC (34%): o-NPOE
−7
harmaceutical analysis
rostaglandin E1 and Deoxycholate
(60%). The proposed electrodes exhibit nernstian response in the concentration ranges of 2.1 × 10 M to
1.0 × 10−2 M and 4.4 × 10−7 M to 1.0 × 10−2 M with detection limit of 1.5 × 10−7 M and 3.3 × 10−7 M, respec-
tively. Both the membrane electrodes perform satisfactorily over pH ranges of (3.5–7.5 and 4.0–7.0) with
fast response times (11 s and 13 s), respectively. These drugs (PB and NB) were further utilized as different
ion-pairs of Prostaglandin E1 (PGE1) and Deoxycholate (DOC) in poly (vinyl chloride)-based membrane
electrodes for the determination of bioavailability of Prostaglandin E1 and Deoxycholate in plasma of
different patients.
. Introduction
Quaternary ammonium drugs have a number of applica-
ions in medical science such as propantheline bromide (PB),
,N-Diisopropyl-N-methyl-N-[2-(xanthen-9ylcarbonyloxy)ethyl]
mmonium bromide is an antimuscarinic [1] agent used for the
reatment of excessive sweating (hyperhidrosis) [2], cramps or
pasms of the stomach, intestines (gut) or bladder, and involun-
ary urination (enuresis) [3]. It can also be used to control the
ymptoms of irritable bowel syndrome and similar conditions.
imilarly neostigmine bromide (NB), [3-(dimethylcarbamoyloxy)
henyl]- trimethylazanium, a cholinesterase inhibitor used in the
reatment of myasthenia gravis [4–7] and to reverse the effects
f muscle relaxants such as gallamine and tubocurarine. Neostig-
ine, unlike physostigmine, does not cross the blood–brain
arrier. There are a lot of techniques for the determination of
uaternary ammonium drugs in pharmaceutical preparation
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as propantheline drug can be assayed by HPLC [8], GC–MS [9]
and homidium bromide can be assayed by ELISA [10], HPLC [11]
and neostigmine bromide can be assayed by HPLC [12], ES–MS
[13] and UV (as per U.S.P). In these techniques involve the use
of complex procedures; several sample manipulations, require
long analysis time and are not easy to automate. Development
and applications of ion-selective electrodes in pharmaceutical
preparation [14] analysis have enabled the direct and selec-
tive measurement of the activity of various organic cations or
anions of pharmaceutical interest, in most instances without
prior separation of the active substance from the formulation
matrix.
To improve the analytical method for the quantitative anal-
ysis of these drugs, we developed and report the construction,
performance characteristics and analytical applications of two
potentiometric sensors PB-TPB and NB-TPB, based on the use of the
ion-association complexes of NaTPB. These ion-association com-
plexes show enhancement of lipophilicity and stability of drug
molecules and their utility can be expressed by using them as
an electroactive material in PVC based membrane sensors for the
determination of their respective drug concentrations (PB+ and
NB+) in the presence of excipient (coating and stabilizing) materi-
als without separation and extraction process from pharmaceutical
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osage (tablets and capsules) and pure drug (APIs; active pharma-
eutical ingredients) forms.
. Experiment
.1. Reagents and materials
High molecular weight polyvinyl chloride (PVC), propantheline
romide (PB), sodium deoxycholate, Prostaglandin E1 and neostig-
ine bromide (NB) Aldrich (Wisconsin, USA), o-nitrophenyl octyl
ther (o-NPOE) Fluka (Ronkonkoma, NY), tri-n-butylphosphate
TBP) BDH (Poole, England), chloronapthalene (CN), dibutylphtha-
ate (DBP), sodium tetraphenylborate (NaTPB) and dibutyl(butyl)
hosphonate (DBBP) Mobile (Alabama, USA).
.2. Preparation of ion-association complexes
The ion-association complexes PB-TPB and NB-TPB were pre-
ared by taking same concentration of drug (PB and NB) and counter
on (NaTPB) in methanol. Propantheline bromide (1.0 × 10−4 M) and
eostigmine bromide (1.0 × 10−3 M) were separately mixed with
he NaTPB having the concentrations same corresponding to drug
oncentration in methanol (50 mL) on constant stirring up to 12 h
t 100 ◦C. The precipitates were formed, ﬁltered, washed (with
ethanol solution) and ﬁnally dried.
PB-TPB: yield: 82%, colorless, UV–vis (max/nm) (0.006% (w/v)
ethanol): 246, 282. Elemental analysis % observed was, C = 81.50,
= 1.2, O = 6.3, N = 1.8, H = 6.6 and calculated % was C = 82.0, B = 1.6,
= 6.9, N = 2.0, H = 7.2. The observed elemental analysis is consistent
ith the theoretical data obtained on the basis of structure of ion-
air (PB-TPB).
.2.1. Stoichiometry of PB-TPB
The stoichiometry of the ion-pair (PB-TPB) was studied by using
ob’s method [15]. The concentration of propantheline bromide (PB)
nd NaTPB was taken to be 2.0 × 10−3 M. Nine methanolic solu-
ions were prepared containing propantheline and NaTPB in various
olar ratios so that the ﬁnal volume always amounted to 10 mL
ith the addition of acetate buffer (0.05 M) pH 4.5. The extraction
as performed using 10 mL of chloroform and the absorbance was
easured at 246 nm. The plot reaches maximum value at a mole
raction Xmax = 0.5 (Fig. 1), which indicates the formation of 1:1
on-pair association.
Fig. 1. Stoichiometry of ion-pair, PB-TPB by Job’s curve method.Fig. 2. Stoichiometry of ion-pair, NB-TPB by Job’s curve method.
NB-TPB: yield: 78%, color: red–orange, UV–vis (max/nm) (0.02%
(w/v) solution in 0.5 M sulfuric acid): 260 and 266. Elemental anal-
ysis % observed was, C = 78.6, H = 6.6, B = 1.9, O = 6.4, N = 5.10 and
calculated % was C = 79.0, H = 7.1, B = 2.0, O = 6.5, N = 5.1. The observed
elemental analysis is consistent with the theoretical data obtained
on the basis of structure of ion-pair (NB-TPB).
2.2.2. Stoichiometry of NB-TPB
The stoichiometry of the ion-pair (NB-TPB) was also studied by
using Job’s method. The concentration of neostigmine bromide (NB)
and NaTPB was taken to be 2.0 × 10−3 M. Nine methanolic solutions
were prepared containing neostigmine bromide and NaTPB in vari-
ous molar ratios so that the ﬁnal volume always amounted to 10 mL
with the addition of citrate buffer (0.03 M) pH 7.0. The extraction
was performed using 10 mL of acetone and the absorbance was
measured at 266 nm. The plot reaches maximum value at a mole
fraction Xmax = 0.5 (Fig. 2), which indicates the formation of 1:1
ion-pair association.
2.3. Electrode fabrication
The membranes have been fabricated by dissolving appropriate
amounts of ion-pairs (PB-TPB and NB-TPB), PVC and plasticizers CN,
DOP, o-NPOE in THF (5 mL). The components were added in terms
of weight percentages. A homogenous mixture was obtained after
complete dissolution of all the components, which was then con-
centrated by evaporating THF and then poured into polyacrylate
rings placed on a smooth glass plate. The membranes of 0.4-mm
thickness were removed carefully from the glass plate and glued
to one end of a “pyrex” glass tube. It is known that the sensitivity,
linearity and selectivity obtained for a given ionophore depends sig-
niﬁcantly on the membrane composition and nature of plasticizer
used [16]. Thus, the ratio of membrane ingredients, time of con-
tact, concentration of equilibrating solution, etc. were optimized
after a good deal of experimentation to provide membranes, which
generate reproducible and stable potentials.
2.4. Standard solutionThe standards of proposed drugs were purchased from central
drug laboratory (Calcutta, India). Propantheline bromide (standard)
containing not less than 90.0% and not more than 110.0% of the
labeled amount of C23H30BrNO3, and similarly of neostigmine bro-
mide (standard) containing not less than 98.0% and not more than
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Table 1
The optimization of PB-TPB and NB-TPB carrier based PVC membranes.
Sensor no. Composition of membranes (% w/w) Working concentration
range (M)




1 0 (PB-TPB) 36 64 (DBP) N.M N.M N.M N.M
2 6 (PB-TPB) 32 62 (DOP) 4.4 × 10−5–1.0 × 10−2 3.3 × 10−5 58.6 16
3 9 (PB-TPB) 91 0 3.3 × 10−3–1.0 × 10−2 2.3 × 10−3 56.7 27
4 6 (PB-TPB) 34 60 (CN) 3.5 × 10−5–1.0 × 10−2 1.0 × 10−5 58.0 15
5 6 (PB-TPB) 34 60 (DBP) 7.6 × 10−4–1.0 × 10−2 4.3 × 10−4 57.9 14
6 6 (PB-TPB) 34 60 (o-NPOE) 2.1 × 10−7–1.0 × 10−2 1.5 × 10−7 59.3 11
7 8 (PB-TPB) 34 58 (o-NPOE) 5.1 × 10−7–1.0 × 10−2 4.2 × 10−7 59.0 11
8 10 (PB-TPB) 30 60 (o-NPOE) 6.7 × 10−6–1.0 × 10−2 5.3 × 10−6 58.7 12
9 5 (PB-TPB) 35 60 (o-NPOE) 8.5 × 10−7–1.0 × 10−2 7.8 × 10−7 58.8 13
10 0 (NB-TPB) 36 64 (DBP) N.M N.M N.M N.M
11 6 (NB-TPB) 32 62 (DOP) 6.2 × 10−5–1.0 × 10−2 5.4 × 10−5 57.7 14
12 9 (NB-TPB) 91 0 4.3 × 10−3–1.0 × 10−2 3.4 × 10−3 56.6 28
13 6 (NB-TPB) 34 60 (CN) 4.3 × 10−5–1.0 × 10−2 2.3 × 10−5 58.3 17
14 6 (NB-TPB) 34 60 (DBP) 8.3 × 10−4–1.0 × 10−2 5.4 × 10−4 58.2 15
15 6 (NB-TPB) 34 60 (o-NPOE) 4.4 × 10−7–1.0 × 10−2 3.3 × 10−7 59.1 13



































m16 8 (NB-TPB) 34 58 (o-NPOE) 6.8 × 10 –1.0
17 10 (NB-TPB) 30 60 (o-NPOE) 7.4 × 10−6–1.0
18 5 (NB-TPB) 35 60 (o-NPOE) 1.3 × 10−6–1.0
.M: not measurable.
02.0% of C12H19BrN2O2, calculated on the dried basis. The standard
olutions of both the drugs (1.0 × 10−2 M) were prepared by dissolv-
ng an appropriate amount of drugs in double distilled water using
cetate buffer (0.05 M) pH 4.5 and citrate buffer (0.03 M) pH 7.0 for
ropantheline bromide and neostigmine bromide, respectively. The
orking solutions of the drugs (1.0 × 10−8 M to 1.0 × 10−3 M) were
urther prepared by simple dilution method using their respective
uffers as mentioned above.
.5. Conditioning of membranes and potential measurements
The electrode bodies ﬁlled with internal standard drug solu-
ions of same concentration (1.0 × 10−2 M) of respective drugs (PB
nd NB) were separately equilibrated for 24 h in 1.0 × 10−3 M stan-
ard drug solutions using acetate and citrate buffers for respective
rugs (PB and NB) prior to potential measurements. The poten-
ial measurements were carried out at 25±1 ◦C using saturated
alomel electrode (SCE) as reference electrode with the following
ell assembly.
Hg/Hg2Cl2|KCl (satd.)|0.001 M PB or NB ||PVC membrane||test
olution|Hg/Hg2Cl2|KCl (satd.)
.6. GC conditions
The initial temperature 60 ◦C was held for 2 min, the tempera-
ure was programmed to 200 ◦C at a rate of 20 ◦C/min, than to 300 ◦C
t a rate of 30 ◦C/min; this temperature being maintained for 1 min.
njection port and transfer line temperatures were set at 130 ◦C and
80 ◦C, respectively. Helium with a ﬂow rate of 1 mL/min was used
s a carrier gas.
. Result and discussion
.1. Optimization of membrane
The composition of PB-TPB and NB-TPB carrier (ion-pairs) based
VC membranes were optimized by varying the ratio of ion-pairs,
VC and plasticizers to obtained membranes showing best per-
ormance regarding working concentration range, slope, detection
imit and response time. It was observed that the membranes incor-
orating the ingredients in the ratio (w/w (%) mg) 6 (ion-pair): 34
PVC): 60 (o-NPOE) as shown in Table 1, displayed the best perfor-
ance. The membranes without ion-pairs were also prepared and5.2 × 10 58.9 12
2 6.2 × 10−6 57.8 18
2 8.6 × 10−7 59.0 13
investigated that the no potentiometric response were produced.
Thus it can be proved that all the potentiometric responses in the
membranes were only due to the presence of ion-pairs.
3.2. Calibration plot
The best responsive membrane electrode sensors (nos. 6 and 15)
equilibrated in 1.0 × 10−3 M drug solution using acetate (0.05 M) pH
4.5 and citrate buffer (0.03 M) pH 7.0, respectively and potentio-
metrically calibrated using standard drug solutions (1.0 × 10−8 M
to 1.0 × 10−3 M) at 25 ± 3 ◦C with the help of pH meter and the
obtained result shows that PB-TPB and NB-TPB carriers based
membranes have detection limit of 1.0 × 10−7 M and 2.5 × 10−7 M,
respectively.
3.3. Selectivity
The selectivity coefﬁcient KPotA,B measured by separate solution










where KPotA,B is the potentiometric selectivity coefﬁcient; EA and EB
are the potential readings observed after 1 min of exposing the sen-
sor to the same concentration of PB or NB and interfering species
(1×10−3 M each) alternatively, aA the activities or concentration of
PB or NB; ZA and ZB are the charges of PB or NB and interfering
ions and S is slope of calibration graph (mV/decade of activity). The
results reveal reasonable selectivity of PB-TPB (sensor no. 6) and
NB-TPB (sensor no. 15) in presence of many related substances and
drug stabilizing agents such as starch, lactose and sucrose is shown
in Table 2.
3.4. Effect of pH
The pH dependence of the proposed electrodes, sensor nos. 6 and
15 were tested over the range of 3.0–8.0 for 1.0 × 10−4 M of both PB
and NB separately as shown in Fig. 3. The pH of the solution was
adjusted by the addition of nitric acid or hexamine. It is clear from
Fig. 2 that the useful pH ranges are 3.5–7.5 (sensor no. 6) and 4.0–7.0
(sensor no. 15) as the potential remains constant in these pH ranges.
The interference in the potentials were observed below 3 or higher
to 8 pH only due to the participations of H+ and OH−, respectively in
V.K. Gupta et al. / Electrochimica Acta 54 (2009) 6700–6706 6703
Table 2
The selectivity of PB-TPB and NB-TPB carrier based PVC membrane electrodes in
presence of interfering species.
Interfering species Selectivity coefﬁcient (KPotA,B)
PB-TPB NB-TPB
Deoxycholate 1.3 × 10−4 1.5 × 10−4
Prostaglandin E1 3.1 × 10−4 3.6 × 10−4
Cl− 1.5 × 10−3 2.3 × 10−3
Br− 3.2 × 10−2 3.4 × 10−2
CN− 1.5 × 10−2 1.7 × 10−2
SCN− 1.3 × 10−2 1.1 × 10−2
CH3COO− 3.3 × 10−4 3.1 × 10−4
Caffeine 1.6 × 10−4 1.3 × 10−4
Urea 2.1 × 10−4 2.4 × 10−4
Salbutamol sulfate 3.2 × 10−3 3.6 × 10−3
Ephedrine hydrochloride 4.2 × 10−3 4.6 × 10−4
Gelatin 2.7 × 10−4 2.3 × 10−4
Tryptophan 2.1 × 10−3 1.9 × 10−3

























The potentiometric characteristics of the proposed sensors (sensor nos. 6 and 15).
Parameter Proposed electrodes*
Sensor no. 6 (PB-TPB) Sensor no. 15 (NB-TPB)
Detection limit (M) 1.5 × 10−7 3.3 × 10−7
Working concentration
range (M)




Working pH range 3.5–7.5 4.0–7.0
Response time (s) 11 13actose 3.2 × 10−4 2.9 × 10−4
ucrose 1.2 × 10−4 2.1 × 10−4
lucose 5.1 × 10−4 4.7 × 10−4
harge transport process of membranes, thereby causing distortion
n results.
.5. Effect of plasticizers
It is well known that the sensitivity and selectivity of
on-selective electrodes strongly depend on the membrane compo-
itions and the nature of the plasticizer used [17–19]. The nature of
he plasticizer inﬂuences the dielectric constant of the membrane
hase, the mobility of the ionophore molecules, and the forms of
he ligands [20–22]. To investigate the effect of plasticizers, PVC
embranes with the different plasticizers DOP, DBP, CN and o-NPOE
ere prepared using PB-TPB and NB-TPB as the sensing membrane
omponents. The potentiometric responses and results including
lope, response time and working concentration range are sum-
arized in Table 1. According to the data presented in Table 1, of
he four different plasticizers used, o-NPOE is the most effective.
his indicates that o-NPOE plasticizes the membrane, dissolves the
on-association complex, and adjusts both the membrane permit-
ivity and the mobility of the ion-exchanger sites to give the highest
ossible selectivity and sensitivity [23].
ig. 3. Effect of pH on the performance of best responsive membrane electrodes
nos. 6 and 15).Life span (months) 2.0 1.5
R.S.D 0.86 1.10
* Average of ﬁve replicates.
3.6. Response (tR, s) and lifetime of the electrodes
The electrodes, having membranes without solvent mediators
gave a steady response times (tR) of 27 s and 28 s for sensor nos.
3 and 12, respectively whereas after adding the solvent mediators
(DBP, DOP, CN and o-NPOE) the electrodes achieved an equilibrium
response within 18–11 s over a whole concentration range (Table 1).
The experimental results show that the lifetime of the proposed
sensors (6 and 15) were about 2 and 1.5 months, respectively. During
these times, the detection limits and the slopes of the proposed
sensors remained almost constant. The electrochemical behaviors
of proposed sensors (6 and 15) gradually deteriorated after 2 and
1.5 months, which can be attributed to aging of the polymer (PVC),
plasticizer and ion-pairs. All the potentiometric characteristics of
proposed sensors (nos. 6 and 15) in consecutive ﬁve measurements
are summarized in Table 3.
3.7. Analytical applications
3.7.1. Application to pharmaceutical preparations
The proposed sensors (nos. 6 and 15) were applied for analy-
sis of commercial tablets of propantheline bromide (15 mg) and
neostigmine bromide (15 mg) by using standard addition method
[24]. In the standard addition method, known small increments
of 1.0 × 10−2 M standard drug solutions were added to 50.0 mL
aliquots of various concentrations (1.0 × 10−7–1.0 × 10−3 M) of
pharmaceutical preparations (tablets). The changes in potentials
were recorded for each increment and were used to calculate the











where Cx and Vx are the concentration and volume of the unknown,
respectively, Cs and Vs are the concentration and volume of the
standard, respectively, S is the slope of the calibration graph, and
E is the change in potential due to the addition of standards. The
results are summarized in Table 4.
During analysis it was observed that both sensors (nos. 6 and 15)
work well in pharmaceutical preparation measurements of most of
the aqueous solutions except plasma and blood samples as some
biologically active molecules (Prostaglandin E1 and Deoxycholate)
interfere with these drugs measurements.
3.7.2. Application in bioavailability of biologically active
molecules (Prostaglandin E1 and Deoxycholate) by ion-pairing
with quaternary ammonium salts and fabricating in PVC
membranes
The ion-pairs of drugs (propantheline bromide and neostig-
mine bromide) with biologically active molecules, Prostaglandin
E1 (PGE1) and Deoxycholate (DOC) were synthesized by reported
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Table 4
Determination of propantheline bromide and neostigmine bromide in pharmaceutical preparation using sensor nos. 6 and 15, respectively.
Drug Active ingredient (mg/tablet) Sample taken (mg) Drug recoverya (%)
Sensor no. 6 Sensor no. 15 I.Pb
Propantheline bromide 15 15.0 98.6 ± 0.45 – 98.0–105
Neostigmine bromide 15 15.0 – 93.2 ± 0.65 92.5–107.5
a Average of ﬁve measurements.
b Indian Pharmacopoeia (1996).









ethod [25] and their proposed structural formulas were given in
igs. 4–7. Further scheme of synthesis was described by the follow-
ng equation as in reported methods [26]:A+W + Y−W  (QA+Y−)W  (QA+Y−)o (3)
ere the cation is a quaternary ammonium pharmacon (QA+) which
nteracts with the counter ion (Y−) forming a less polar ion-pair
QA+Y−) and for this equilibrium the Kip, the formation constant (or
Fig. 6. Structure oof PB-DOC.





(4)The distinct and thermodynamically stable species (QA+Y−) formed
partitions between the aqueous (w) and organic phases (o) which
equilibrium can be characterized by the (true) partition coefﬁcient
(P) of the ion-pair (Eq. (5)). The related other equilibrium constants
f NB-PGE1.









































Lipophilicity of quaternary ammonium drugs (QA).
Quaternary ammonium drug (QA) log p (±S.D)a
Propantheline bromide −1.11 (0.04)
Neostigmine bromide <−3.5 (0.03)
Biologically active molecule log P (±S.D)
Deoxycholate 3.62 (0.04)




Hydrogen maleate 0.18 (0.05)
Acetate −0.15 (0.02)
P-toluenesulfonate −0.65 (0.06)
that maximum lipophilicity of QAs was observed at 1:50 molar ratio
(Figs. 8 and 9) and it was concluded that PGE1 and DOC have max-
imum lipophilicity and ion-pairing ability effect on both the QAs.
The analysis of the enhancement in lipophilicity suggests that the
size of the counter ion may be a determining factor.Fig. 7. Stru
apparent partition coefﬁcient of the ion-pair, P′, and that of cation,
QA
′; extraction constant, Kex) and their relationships are summa-


















og Kex = log P ′ − log [Y−]w (9)
og P = log Kex − log Ktp (10)
All these equations describe how the partition coefﬁcient is
elated to the stability constant and it was concluded that the exis-
ence of ion-pairs even in aqueous solutions which may emerge
hen ions involved are relatively hydrophobic. It has also been
stablished in the formation of such type of ion-pairs, out of the
lectrostatic forces other interactions, e.g. hydrophobic and polar
nes, also play signiﬁcant role. The log P values of quaternary
mmonium drugs (QA) in bromide salt form as used in medicine
without external counter ions), were determined by shake-ﬂask
echnique in order to describe the “intrinsic” lipophilicity of these
olecules. The QA salts according to their molar absorptivity, were
issolved in the mixture of 1:20 (water/octanol) and absorbance
as taken at their characteristic max (246 for PB and 266 for NB)
nd log P values were determined by the following equation:





here Ao and Aw are absorbance in aquoeous before and after
artitions, from this equation other parameters also calculated as
iscussed in above coorelated equation and results were summa-
ized in Table 5. It was observed that both the compounds have
ery low lipophilicity and will have very low signiﬁcant active
oncentration in blood particularly of neostigmine bromide. To
vercome this problem an ion-pair method was selected to increase
he lipophilicity and similarly log P values of some selected bio-
ogically active molecules were also determined to ﬁnd out the
uitable ion-pairing molecules and results were compiled in Table 5.
t was observed that Deoxycholate and Prostaglandin E1 have max-
mum lipophilicity in comparison to others, therefore by keeping
his view in mind a different approach of PVC based sensor was
tilized to determine the bioavailability of these two biologically
ctive molecules having many biological applications in the body.Pyruvate −1.20 (0.03)
Mesylate −2.31 (0.03)
a Measurement of three replicates at 1:20 (water/octanol).
3.7.2.1. Effect of counter ions on the lipophilicity of QAs. The effect of
counter ions (Prostaglandin E1 and Deoxycholate) on the lipophilic-
ity of QAs (propantheline bromide and neostigmine bromide) were
studied under different QA+/Y− molar ratios and it was observedFig. 8. Effect of counter ions (PGE1 & DOC) on the lipophilicity of propantheline
bromide.
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Table 6
Determination of bioavailability of Prostaglandin E1 and Deoxycholate in blood plasma of different patients.






Normal person 25–47 (M&F) 0.5–9.8 5.43 ± 2.4 4.26 ± 2.5
Cirrhosis patient 27–48 (M&F) 10–12.7 9.43 ± 2.1 9.12 ± 2.1
Chronic hepatitis patient 27–55 (M&F) 15–72 33.8 ± 3.5 33.4 ± 3.1






Normal persons 26–67 (M&F) 5.6 × 10−11–6.8 × 10−11 4.6 × 10−7 ± 4.1 1.6 × 10−8 ± 3.5
Asthma patient treated with alprostadil 26–67 (M&F) 4.5 × 10−8–5.4 × 10−7 5.3 × 10−7 ± 2.5 4.5 × 10−8 ± 4.1
a Samples collected from 25 patients.
b ±Standard deviation.
c M (male), F (female).






























Schmid, U.F. Spichiger, W. Simon, Anal. Chim. Acta 289 (1994) 1.ig. 9. Effect of counter ions (PGE1 & DOC) on the lipophilicity of neostigmine bro-
ide.
.7.2.2. Fabrication of membranes. Different membranes were fab-
icated by dissolving different amounts of plasticizers, PVC and
on-pairs and membranes were optimized as mentioned above
nd it was observed that membranes with PVC(30): o-NPOE(60):
A-PGE1(10) and PVC(30): o-NPOE(60): QA-DOC(10) (w/w) ratio
how best performance characteristics. The standard solutions
5.0 × 10−8–1.0 × 10−2) of PGE1 and DOC were prepared by using
hosphate buffer (H2PO4− and HPO4−2, pH 6.5)
.7.2.3. Bioavailability of PGE1 and DOC. The bioavailability of
rostaglandin E1 and Deoxycholate in blood was determined by
ollecting the blood samples of different patients from near city
ospital and centrifuge at 8000 rpm to remove the cell debris and
btained plasma can be directly diluted (5 × 10−8–1.0 × 10−2 M) by
sing phosphate buffer (H2PO4− and HPO4−2, pH 6.5) and may
tored in refrigerator by adding small amount of sodium citrate
olution, if measurement was to be done latter (not exceeding four





[er gas: He (1 mL/min).
PGE1(10) and PVC(30): o-NPOE(60): QA-DOC(10) were equilibrated
for two days in 1.0 × 10−2 M standard solution of Prostaglandin E1
and Deoxycholate, respectively and potentiometric responses were
studied out against the diluted plasma solutions and results com-
paratively with GC data were compiled in Table 6.
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